Hemolytic transfusion reaction (HTR)

Specialty: Hematology

Recommendations:

IVIG may be considered as an option among supportive therapies for urgent situations in this disorder.

Dose:

Up to 2 g/kg divided over 2 to 5 consecutive days, short term up to 3 months.